Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography.

Sprague BL, Coley RY, Kerlikowske K, Rauscher GH, Henderson LM, Onega T, Lee CI, Herschorn SD, Tosteson ANA, Miglioretti DL.

JAMA Netw Open. 2020 Mar 2;3(3):e201759. doi: 10.1001/jamanetworkopen.2020.1759.

2.
3.

Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization.

Buist DSM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, Bowles EJA, Miglioretti DL, Specht J, Rauscher GH, Sprague BL, Onega T, Lee JM.

J Am Coll Radiol. 2020 Jan 28. pii: S1546-1440(19)31483-8. doi: 10.1016/j.jacr.2019.12.020. [Epub ahead of print]

PMID:
32004483
4.

Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed".

Schifferdecker KE, Tosteson ANA, Kaplan C, Kerlikowske K, Buist DSM, Henderson LM, Johnson D, Jaworski J, Jackson-Nefertiti G, Ehrlich K, Marsh MW, Vu L, Onega T, Wernli KJ.

J Gen Intern Med. 2019 Dec 2. doi: 10.1007/s11606-019-05560-z. [Epub ahead of print]

PMID:
31792869
5.

Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.

Piepkorn MW, Longton GM, Reisch LM, Elder DE, Pepe MS, Kerr KF, Tosteson ANA, Nelson HD, Knezevich S, Radick A, Shucard H, Onega T, Carney PA, Elmore JG, Barnhill RL.

JAMA Netw Open. 2019 Oct 2;2(10):e1912597. doi: 10.1001/jamanetworkopen.2019.12597.

6.

Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age.

Demb J, Abraham L, Miglioretti DL, Sprague BL, O'Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D.

J Natl Cancer Inst. 2019 Sep 6. pii: djz172. doi: 10.1093/jnci/djz172. [Epub ahead of print]

PMID:
31593591
7.

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.

Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ.

J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.

PMID:
31410813
8.

Assessing data availability and quality within an electronic health record system through external validation against an external clinical data source.

Palmer EL, Higgins J, Hassanpour S, Sargent J, Robinson CM, Doherty JA, Onega T.

BMC Med Inform Decis Mak. 2019 Jul 25;19(1):143. doi: 10.1186/s12911-019-0864-2.

9.

Building a tobacco user registry by extracting multiple smoking behaviors from clinical notes.

Palmer EL, Hassanpour S, Higgins J, Doherty JA, Onega T.

BMC Med Inform Decis Mak. 2019 Jul 25;19(1):141. doi: 10.1186/s12911-019-0863-3.

10.

Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.

Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA.

J Natl Cancer Inst. 2020 Mar 1;112(3):238-246. doi: 10.1093/jnci/djz137.

PMID:
31292633
11.

Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging.

Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O'Meara ES, Miglioretti DL.

JAMA Intern Med. 2019 Jul 1. doi: 10.1001/jamainternmed.2019.1758. [Epub ahead of print]

PMID:
31260054
12.

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer.

Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL.

Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.

PMID:
31161975
13.

Breast Cancer Prognostic Factors in the Digital Era: Comparison of Nottingham Grade using Whole Slide Images and Glass Slides.

Davidson TM, Rendi MH, Frederick PD, Onega T, Allison KH, Mercan E, Brunyé TT, Shapiro LG, Weaver DL, Elmore JG.

J Pathol Inform. 2019 Apr 3;10:11. doi: 10.4103/jpi.jpi_29_18. eCollection 2019.

14.

Middle-aged death and taxes in the USA: Association of state tax burden and expenditures in 2005 with survival from 2006 to 2015.

MacKenzie TA, Houle J, Jiang S, Onega T.

PLoS One. 2019 Apr 12;14(4):e0214463. doi: 10.1371/journal.pone.0214463. eCollection 2019.

15.

Concordance of Rural-Urban Self-identity and ZIP Code-Derived Rural-Urban Commuting Area (RUCA) Designation.

Onega T, Weiss JE, Alford-Teaster J, Goodrich M, Eliassen MS, Kim SJ.

J Rural Health. 2020 Mar;36(2):274-280. doi: 10.1111/jrh.12364. Epub 2019 Mar 26.

PMID:
30913340
16.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL; Population-based Research Optimizing Screening Through Personalized Regimen (PROSPR) Consortium.

JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078.

17.

Monitoring of Technology Adoption Using Web Content Mining of Location Information and Geographic Information Systems: A Case Study of Digital Breast Tomosynthesis.

Onega T, Kamra D, Alford-Teaster J, Hassanpour S.

JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00150.

18.

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K.

J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.

PMID:
30625040
19.

Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.

Austin AM, Kapadia NS, Brooks GA, Onega TL, Eliassen AH, Tamimi RM, Holmes M, Wang Q, Grodstein F, Tosteson ANA.

Breast Cancer Res Treat. 2019 Apr;174(3):759-767. doi: 10.1007/s10549-018-05098-4. Epub 2019 Jan 3.

20.

Statins associate with improved mortality among patients with certain histological subtypes of lung cancer.

Ung MH, MacKenzie TA, Onega TL, Amos CI, Cheng C.

Lung Cancer. 2018 Dec;126:89-96. doi: 10.1016/j.lungcan.2018.10.022. Epub 2018 Oct 25.

21.

Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE.

J Womens Health (Larchmt). 2019 Aug;28(8):1051-1059. doi: 10.1089/jwh.2018.6997. Epub 2018 Nov 27.

PMID:
30481098
22.

Evaluating Breast Cancer Care Coordination at a Rural National Cancer Institute Comprehensive Cancer Center Using Network Analysis and Geospatial Methods.

Moen EL, Kapadia NS, O'Malley AJ, Onega T.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):455-461. doi: 10.1158/1055-9965.EPI-18-0771. Epub 2018 Oct 30.

23.

Screening mammography use in older women according to health status: a systematic review and meta-analysis.

Demb J, Akinyemiju T, Allen I, Onega T, Hiatt RA, Braithwaite D.

Clin Interv Aging. 2018 Oct 12;13:1987-1997. doi: 10.2147/CIA.S171739. eCollection 2018.

24.

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL.

AJR Am J Roentgenol. 2018 Nov;211(5):957-963. doi: 10.2214/AJR.17.19350. Epub 2018 Sep 20.

25.

Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.

Onega T, Barnhill RL, Piepkorn MW, Longton GM, Elder DE, Weinstock MA, Knezevich SR, Reisch LM, Carney PA, Nelson HD, Radick AC, Elmore JG.

JAMA Dermatol. 2018 Oct 1;154(10):1159-1166. doi: 10.1001/jamadermatol.2018.2388.

26.

Multi-level Influences on Breast Cancer Screening in Primary Care.

Onega T, Tosteson TD, Weiss J, Haas JS, Goodrich M, DiFlorio R, Brackett C, Clark C, Harris K, Tosteson ANA.

J Gen Intern Med. 2018 Oct;33(10):1729-1737. doi: 10.1007/s11606-018-4560-1. Epub 2018 Aug 3.

27.

Addressing Potential Health Disparities in the Adoption of Advanced Breast Imaging Technologies.

Miles RC, Onega T, Lee CI.

Acad Radiol. 2018 May;25(5):547-551. doi: 10.1016/j.acra.2017.05.021. Review.

28.

Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.

Elder DE, Piepkorn MW, Barnhill RL, Longton GM, Nelson HD, Knezevich SR, Pepe MS, Carney PA, Titus LJ, Onega T, Tosteson ANA, Weinstock MA, Elmore JG.

J Am Acad Dermatol. 2018 Jul;79(1):52-59.e5. doi: 10.1016/j.jaad.2018.02.070. Epub 2018 Mar 7.

29.

Preoperative breast MRI and mortality in older women with breast cancer.

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, Hubbard RA.

Breast Cancer Res Treat. 2018 Jul;170(1):149-157. doi: 10.1007/s10549-018-4732-z. Epub 2018 Mar 7.

30.

Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer.

Chowdhury M, Euhus D, O'Donnell M, Onega T, Choudhary PK, Biswas S.

Breast Cancer Res Treat. 2018 Jul;170(1):143-148. doi: 10.1007/s10549-018-4736-8. Epub 2018 Mar 6.

31.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

32.

Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):458-468. doi: 10.1001/jamainternmed.2017.8549.

33.

Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B.

Acad Radiol. 2018 Sep;25(9):1118-1127. doi: 10.1016/j.acra.2017.12.028. Epub 2018 Feb 9.

34.

Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI.

J Womens Health (Larchmt). 2018 Jun;27(6):748-754. doi: 10.1089/jwh.2017.6623. Epub 2018 Jan 17.

35.

Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer.

Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T.

J Womens Health (Larchmt). 2018 Aug;27(8):987-993. doi: 10.1089/jwh.2017.6428. Epub 2018 Jan 15.

36.

Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.

Nutter EL, Weiss JE, Marotti JD, Barth RJ Jr, Eliassen MS, Goodrich ME, Petersen CL, Onega T.

Cancer. 2018 Apr 1;124(7):1350-1357. doi: 10.1002/cncr.31202. Epub 2017 Dec 20.

37.

Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T.

J Gen Intern Med. 2018 Mar;33(3):275-283. doi: 10.1007/s11606-017-4224-6. Epub 2017 Dec 6.

38.

Correlation between obesity and fat-infiltrated axillary lymph nodes visualized on mammography.

diFlorio Alexander RM, Haider SJ, MacKenzie T, Goodrich ME, Weiss J, Onega T.

Br J Radiol. 2018 Sep;91(1089):20170110. doi: 10.1259/bjr.20170110. Epub 2018 Jan 5.

39.

An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events.

Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA.

Med Care. 2017 Dec;55(12):e81-e87. doi: 10.1097/MLR.0000000000000352.

40.

Disparities in Geographic Accessibility of National Cancer Institute Cancer Centers in the United States.

Xu Y, Fu C, Onega T, Shi X, Wang F.

J Med Syst. 2017 Nov 11;41(12):203. doi: 10.1007/s10916-017-0850-0.

PMID:
29128881
41.

Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R.

J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

42.

Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.

Tosteson ANA, Yang Q, Nelson HD, Longton G, Soneji SS, Pepe M, Geller B, Carney PA, Onega T, Allison KH, Elmore JG, Weaver DL.

Breast Cancer Res Treat. 2018 Jan;167(1):195-203. doi: 10.1007/s10549-017-4432-0. Epub 2017 Sep 6.

43.

Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.

Geller BM, Frederick PD, Knezevich SR, Lott JP, Nelson HD, Titus LJ, Carney PA, Tosteson ANA, Onega TL, Barnhill RL, Weinstock MA, Elder DE, Piepkorn MW, Elmore JG.

Dermatol Surg. 2018 Feb;44(2):177-185. doi: 10.1097/DSS.0000000000001256.

44.

Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population.

Raffin E, Onega T, Bynum J, Austin A, Carmichael D, Bronner K, Goodney P, Hyams ES.

Cancer Epidemiol. 2017 Oct;50(Pt A):68-75. doi: 10.1016/j.canep.2017.07.015. Epub 2017 Aug 17.

PMID:
28822325
45.

Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS).

Chen Y, Marotti JD, Jenson EG, Onega TL, Johnson KC, Christensen BC.

Exp Mol Pathol. 2017 Aug;103(1):78-83. doi: 10.1016/j.yexmp.2017.07.001. Epub 2017 Jul 12.

46.

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, Carney PA, Titus LJ, Nelson HD, Onega T, Tosteson ANA, Weinstock MA, Knezevich SR, Piepkorn MW.

BMJ. 2017 Jun 28;357:j2813. doi: 10.1136/bmj.j2813. Erratum in: BMJ. 2017 Aug 8;358:j3798.

47.

Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters.

Buist DSM, Gao H, Anderson ML, Onega T, Brandzel S, Rabelhofer MA, Bradford SC, Aiello Bowles EJ.

Prev Med. 2017 Sep;102:49-58. doi: 10.1016/j.ypmed.2017.06.028. Epub 2017 Jun 24.

48.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

49.

Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K.

Acad Radiol. 2017 Oct;24(10):1256-1264. doi: 10.1016/j.acra.2017.03.016. Epub 2017 May 24.

50.

The diagnostic challenge of low-grade ductal carcinoma in situ.

Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV, Pepe MS, Elmore JG.

Eur J Cancer. 2017 Jul;80:39-47. doi: 10.1016/j.ejca.2017.04.013. Epub 2017 May 20.

Supplemental Content

Support Center